User menu

The use of carbon 11-labeled acetate for assessment of aerobic metabolism.

Bibliographic reference Melin, Jacques ; Wijns, William ; Vanoverschelde, Jean-Louis ; Bol, Anne ; Heyndrickx, Guy. The use of carbon 11-labeled acetate for assessment of aerobic metabolism.. In: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, Vol. 1, no. 2 Pt 2, p. S48-57 (1994)
Permanent URL http://hdl.handle.net/2078.1/13466
  1. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 1974;36:413–59.
  2. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321–36.
  3. Fox K. A., Abendschein D. R., Ambos H. D., Sobel B. E., Bergmann S. R., Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically, 10.1161/01.res.57.2.232
  4. Bergmann SR, Sobel BE. Quantification of regional myocardial oxidative utilization with positron emission tomography. In: Bergmann SR, Sobel B, eds. Positron emission tomography of the heart. Mt Kisco, New York: Futura Publishing, 1992:209–29.
  5. Brown M., Marshall D. R., Sobel B. E., Bergmann S. R., Delineation of myocardial oxygen utilization with carbon-11-labeled acetate, 10.1161/01.cir.76.3.687
  6. Buxton D. B., Schwaiger M., Nguyen A., Phelps M. E., Schelbert H. R., Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux, 10.1161/01.res.63.3.628
  7. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11 acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991;32:245–51.
  8. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11 acetate for evaluation of regional myocardial perfusion. J Nucl Med 1991;32:665–72.
  9. Brown MA, Myears DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988;12:1054–63.
  10. Buxton D. B., Nienaber C. A., Luxen A., Ratib O., Hansen H., Phelps M. E., Schelbert H. R., Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography, 10.1161/01.cir.79.1.134
  11. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187–93.
  12. Bol A, Melin JA, Essamri B, et al. Assessment of myocardial oxidative reserve with PET: comparison with Fick oxygen consumption [Abstract]. Circulation 1991;84(suppl):II-425.
  13. Armbrecht J. J., Buxton D. B., Schelbert H. R., Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium, 10.1161/01.cir.81.5.1594
  14. Buck A, Wolpers HG, Hutchins GD, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 1991;32:1950–7.
  15. Sun KT, Chen K, Huang SC, et al. A workable compartmental model for simultaneous measurement of myocardial blood flow and oxygen consumption using C-11 acetate [Abstract]. J Nucl Med 1993;34:4P.
  16. Ng C, Huang S, Schelbert H, Buxton D. Tracer kinetic modeling for delineating C-11 acetate as a tracer for myocardial oxidative metabolism [Abstract]. J Nucl Med 1991;32:910.
  17. Iida H, Rhodes CG, Yamamoto Y, Jones T, de Silva R, Araujo LI. Quantitative measurement of myocardial metabolic rate of oxygen (MRO2) in man using15O2 and positron emission tomography [Abstract]. Circulation 1990;82(suppl): III-614.
  18. Yamamoto Y, de Silva R, Rodes CG, et al. Validation of quantification of myocardial oxygen consumption and oxygen extraction fraction using15O2 and positron emission tomography [Abstract]. Circulation 1991;84(suppl):II-47.
  19. Armbrecht J. J., Buxton D. B., Brunken R. C., Phelps M. E., Schelbert H. R., Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography, 10.1161/01.cir.80.4.863
  20. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with PET and carbon-11 acetate. J Nucl Med 1989;30:1489–99.
  21. Bol A, Iida H, Essamri B, et al. Assessment of myocardial oxidative reserve with PET: comparison of C-11 acetate kinetics with quantitation of metabolic rate of oxygen (MRO2) using O-15 O2 [Abstract]. J Nucl Med 1991;32:988–9.
  22. Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993;71:1351–6.
  23. Tamaki N, Magata Y, Takahashi N, et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med 1993;20:231–7.
  24. Kotzerke J, Hicks RJ, Wolfe E, et al. Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11 acetate kinetics. J Nucl Med 1990;31:1876–93.
  25. Vanoverschelde JL, Wijns W, Essamri B, et al. Hemodynamic and mechanical determinants of myocardial oxygen consumption in the normal human heart: effects of dobutamine. Am J Physiol 1993;265:H1884–92.
  26. Buxton D. B., Mody F. V., Krivokapich J., Phelps M. E., Schelbert H. R., Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium, 10.1161/01.cir.85.5.1842
  27. Heyndrickx G. R., Wijns W., Vogelaers D., Degrieck Y., Bol A., Vandeplassche G., Melin J. A., Recovery of regional contractile function and oxidative metabolism in stunned myocardium induced by 1-hour circumflex coronary artery stenosis in chronically instrumented dogs, 10.1161/01.res.72.4.901
  28. Weinheimer CJ, Brown MA, Nohara R, Perez JE, Bergmann SR. Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. Am Heart J 1993;125:939–49.
  29. Wijns W, Heyndrickx GR, Vogelaers D, et al. Metabolic imaging in postischemic canine myocardium. In: Zaret BL, Beller GA, eds. Nuclear cardiology, state of the art and future directions. St. Louis: Mosby-Year Book, 1993:284–93.
  30. Vanoverschelde JL, Heyndrickx GR, Wijns W, et al. Assessment of myocardial oxidative metabolism with carbon-11 acetate: relation with regional work [Abstract]. Circulation 1989;80:II-515.
  31. Walsh MN, Geltman EM, Brown MA, et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 1989;30:1798–808.
  32. Henes CG, Bergmann SR, Perez JE, Sobel BE, Geltman EM. The time course of restoration of nutritive perfusion, myocardial oxygen consumption, and regional function after coronary thrombolysis. Coronary Artery Dis 1990;1:687–96.
  33. Vanoverschelde J. L., Melin J. A., Bol A., Vanbutsele R., Cogneau M., Labar D., Robert A., Michel C., Wijns W., Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake, 10.1161/01.cir.85.1.9
  34. Gropler RJ, Siegel BA, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992;19:989–97.
  35. Kalff V, Hicks RJ, Hutchins G, Topol E, Schwaiger M. Use of carbon-11 acetate and dynamic positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. Am J Cardiol 1993;71:529–35.
  36. Schelbert HR, Czernin J. PET studies of myocardial blood flow and metabolism in patients with acute myocardial infarction. In: Zaret BL, Beller GA, eds. Nuclear cardiology, state of the art and future directions. St Louis: Mosby-Year Book, 1993:294–302.
  37. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992;20:569–77.
  38. Vanoverschelde J. L., Wijns W., Depre C., Essamri B., Heyndrickx G. R., Borgers M., Bol A., Melin J. A., Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium, 10.1161/01.cir.87.5.1513
  39. Vanoverschelde JL, Bol A, Baudhuin T, et al. Excessive oxygen wasting in response to dobutamine after heart transplantation [Abstract]. Circulation 1993;55:I-172.
  40. Beanlands RSB, Raylman RR, Bach D, Armstrong WF, Bates E, Schwaiger M. Effects of drug therapy for heart failure on oxygen consumption and cardiac efficiency determined using C-11 acetate PET [Abstract]. J Nucl Med 1993;34:107P.
  41. Pike VW, Eakins MN, Allan RM, Selwyn AP. Preparation of [1-11C] acetate: an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot 1982;33:505–12.
  42. Grandin C, Bol A, Coppens A, et al. MRI determination of myocardial contours for partial volume and spillover corrections of PET data [Abstract]. Eur J Nucl Med 1991;18:647.